跳至主要内容
临床试验/NCT00675311
NCT00675311已完成不适用

A Randomized Study of the Clinical and Economic Impact of Remote Monitoring Program With Disease Management Compared to Conventional Diabetes Disease Management Interventions

LifeScan1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2008年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
LifeScan
入组人数
300
试验地点
1
主要终点
The primary study measures for this study include glycemic control and LDL levels, satisfaction with diabetes care, and adherence to diabetes medications and self-monitoring recommendations

研究概览

简要总结

The primary objective of this study is to determine whether remote monitoring in diabetes management is more effective at helping patients manage their disease than a standard disease management program.

详细描述

To determine whether remote monitoring in diabetes management is more effective at helping patients manage their disease.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Between 18 and 64 years of age as of January 1, 2008
  • Diagnosis of diabetes mellitus (listed ICD-9-CM diagnosis code on two or more outpatient claims, or on one or more inpatient admissions or emergency room claims in the most recent 12-month period)
  • Continuously enrolled in a health plan with pharmacy and medical benefits for the most recent 12-month period or with one period of non-enrollment up to only 30 days
  • Able to provide written informed consent for study participation

排除标准

  • Advanced renal disease (one or more claims in the most recent 12-month period) as defined by a claim for nephropathy or creatinine greater than 2.5 mg/dl
  • Selected cancers (one or more claims in the most recent 12-month period)
  • HIV/AIDS (one or more claims in the most recent 12-month period)
  • Heart, liver, kidney, or multiple organ transplant (one or more claims in the most recent 12-month period)
  • Cirrhosis of the liver (one or more claims in the most recent 12-month period)
  • Current participation in another LifeScan study or other diabetes-related clinical trials
  • Medicare is primary source of insurance coverage
  • Unable to understand written and spoken English

结局指标

主要结局

The primary study measures for this study include glycemic control and LDL levels, satisfaction with diabetes care, and adherence to diabetes medications and self-monitoring recommendations

时间窗: 1 Year

次要结局

  • Secondary measures include diabetes-related health-care utilization and physiologic data.(1 Year)

研究者

发起方
LifeScan
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验